Literature DB >> 9768617

Analysis of a large collection of natural HIV-1 integrase sequences, including those from long-term nonprogressors.

L M Skinner1, S L Lamers, J C Sanders, M E Eyster, M M Goodenow, M Katzman.   

Abstract

A large collection of natural HIV-1 integrase (IN) sequences has not previously been described. We reasoned that analysis of such sequences would address whether natural variation of HIV-1 IN contributes to the pathogenesis of AIDS and might also identify amino acid residues important for IN function. Sequences encoding HIV-1 IN were amplified from cryopreserved lymphocytes or plasma obtained at different times from 10 hemophilia patients who had been observed for up to 17 years. The region of the HIV-1 genome that encodes the 288-amino acid IN protein was sequenced from a total of 102 clones; information was obtained for 99.97% of 29,478 amino acid positions. Phylogenetic analysis indicated that patient samples were unique. Interpatient nucleic acid distances ranged from 0.8% to 4.9%, highlighting the tight conservation of this genomic region. No major differences were found between DNA and RNA or between early and late time points from the same patient. Significantly, no amino acid changes that might account for the variable rate of disease progression between patients were evident. Only one amino acid substitution involved a highly conserved residue known to be important for enzymatic activity. However, several interesting amino acid substitutions were noted, including residues within the C-terminal region of the protein for which sequence comparisons between animal retroviruses have not been very informative. These results should encourage the pursuit of anti-integrase therapies, especially inasmuch as the apparent biologic constraints on the IN sequence may deter the development of drug resistance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9768617     DOI: 10.1097/00042560-199810010-00001

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  7 in total

1.  An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.

Authors:  Amy L Harper; Malgorzata Sudol; Michael Katzman
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  In vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients.

Authors:  Mariana Leão de Lima-Stein; Wagner Tadeu Alkmim; Maria Clara de Souza Bizinoto; Luis Fernandez Lopez; Marcelo Nascimento Burattini; Juliana Terzi Maricato; Leila Giron; Maria Cecília Araripe Sucupira; Ricardo Sobhie Diaz; Luiz Mario Janini
Journal:  AIDS Res Hum Retroviruses       Date:  2014-08-25       Impact factor: 2.205

3.  Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection.

Authors:  A L Harper; L M Skinner; M Sudol; M Katzman
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  HIV-miR-H1 evolvability during HIV pathogenesis.

Authors:  Susanna L Lamers; Gary B Fogel; Michael S McGrath
Journal:  Biosystems       Date:  2010-05-31       Impact factor: 1.973

5.  Neuropathogenic SIVsmmFGb genetic diversity and selection-induced tissue-specific compartmentalization during chronic infection and temporal evolution of viral genes in lymphoid tissues and regions of the central nervous system.

Authors:  Aaron B Reeve; Nicholas C Pearce; Kalpana Patel; Katherine V Augustus; Francis J Novembre
Journal:  AIDS Res Hum Retroviruses       Date:  2010-06       Impact factor: 2.205

6.  Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection.

Authors:  Aaron B Reeve; Kalpana Patel; Nicholas C Pearce; Katherine V Augustus; Heber G Domingues; Shawn P O'Neil; Francis J Novembre
Journal:  AIDS Res Hum Retroviruses       Date:  2009-06       Impact factor: 2.205

7.  Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors.

Authors:  Zahida Parveen; Muhammad Mukhtar; Adrienne Goodrich; Edward Acheampong; Ralph Dornburg; Roger J Pomerantz
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.